{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,13]],"date-time":"2026-01-13T14:18:08Z","timestamp":1768313888044,"version":"3.49.0"},"reference-count":75,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2022,11,1]],"date-time":"2022-11-01T00:00:00Z","timestamp":1667260800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2022,11,1]],"date-time":"2022-11-01T00:00:00Z","timestamp":1667260800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100010583","name":"Universit\u00e4t Konstanz","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100010583","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Discov Onc"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Mutations in BAP1 have been identified in a hereditary cancer predisposition syndrome and in sporadic tumours. Individuals carrying familiar BAP1 monoallelic mutations display hypersusceptibility to exposure-associated cancers, such as asbestos-driven mesothelioma, thus BAP1 status has been postulated to participate in gene-environment interaction. Intriguingly, BAP1 functions display also a high degree of tissue dependency, associated to a peculiar cancer spectrum and cell types of specific functions. Mechanistically, BAP1 functions as an ubiquitin carboxy-terminal hydrolase (UCH) and controls regulatory ubiquitination of histones as well as degradative ubiquitination of a range of protein substrates. In this article we provide an overview of the most relevant findings on BAP1, underpinning its tissue specific tumour suppressor function. We also discuss the importance of its epigenetic role versus the control of protein stability in the regulation of genomic integrity.<\/jats:p>","DOI":"10.1007\/s12672-022-00579-x","type":"journal-article","created":{"date-parts":[[2022,11,1]],"date-time":"2022-11-01T11:02:53Z","timestamp":1667300573000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":19,"title":["BAP1 in cancer: epigenetic stability and genome integrity"],"prefix":"10.1007","volume":"13","author":[{"given":"Sabrina","family":"Caporali","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alessio","family":"Butera","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ivano","family":"Amelio","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2022,11,1]]},"reference":[{"issue":"38","key":"579_CR1","doi-asserted-by":"publisher","first-page":"23261","DOI":"10.1073\/pnas.1820838116","volume":"117","author":"MJ Aristizabal","year":"2020","unstructured":"Aristizabal MJ, et al. Biological embedding of experience: a primer on epigenetics. Proc Natl Acad Sci USA. 2020;117(38):23261\u20139. https:\/\/doi.org\/10.1073\/pnas.1820838116.","journal-title":"Proc Natl Acad Sci USA"},{"issue":"12","key":"579_CR2","doi-asserted-by":"publisher","first-page":"1479","DOI":"10.1038\/s41590-021-01058-1","volume":"22","author":"A Liston","year":"2021","unstructured":"Liston A, Humblet-Baron S, Duffy D, Goris A. Human immune diversity: from evolution to modernity. Nat Immunol. 2021;22(12):1479\u201389. https:\/\/doi.org\/10.1038\/s41590-021-01058-1.","journal-title":"Nat Immunol"},{"issue":"1","key":"579_CR3","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s13062-021-00308-4","volume":"16","author":"P Poczai","year":"2021","unstructured":"Poczai P, Santiago-Blay JA. Principles and biological concepts of heredity before Mendel. Biol Direct. 2021;16(1):1\u201317. https:\/\/doi.org\/10.1186\/s13062-021-00308-4.","journal-title":"Biol Direct"},{"issue":"11","key":"579_CR4","doi-asserted-by":"publisher","first-page":"776","DOI":"10.1038\/s41573-020-0077-5","volume":"19","author":"SJ Hogg","year":"2020","unstructured":"Hogg SJ, Beavis PA, Dawson MA, Johnstone RW. Targeting the epigenetic regulation of antitumour immunity. Nat Rev Drug Discov. 2020;19(11):776\u2013800. https:\/\/doi.org\/10.1038\/s41573-020-0077-5.","journal-title":"Nat Rev Drug Discov"},{"issue":"15","key":"579_CR5","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1016\/j.jmb.2021.167094","volume":"433","author":"A Butera","year":"2021","unstructured":"Butera A, Melino G, Amelio I. Epigenetic \u2018Drivers\u2019 of cancer. J Mol Biol. 2021;433(15):167. https:\/\/doi.org\/10.1016\/j.jmb.2021.167094.","journal-title":"J Mol Biol"},{"key":"579_CR6","doi-asserted-by":"publisher","DOI":"10.1007\/s12672-021-00450-5","author":"L Sun","year":"2021","unstructured":"Sun L, Lv S, Song T. O-GlcNAcylation links oncogenic signals and cancer epigenetics. Discov Oncol. 2021. https:\/\/doi.org\/10.1007\/s12672-021-00450-5.","journal-title":"Discov Oncol"},{"issue":"8","key":"579_CR7","doi-asserted-by":"publisher","first-page":"1119","DOI":"10.1101\/gr.261016.120","volume":"30","author":"P Kolovos","year":"2020","unstructured":"Kolovos P, et al. PR-DUB maintains the expression of critical genes through FOXK1\/2- A nd ASXL1\/2\/3-dependent recruitment to chromatin and H2AK119ub1 deubiquitination. Genome Res. 2020;30(8):1119\u201330. https:\/\/doi.org\/10.1101\/gr.261016.120.","journal-title":"Genome Res"},{"issue":"17","key":"579_CR8","doi-asserted-by":"publisher","first-page":"3526","DOI":"10.1016\/j.molcel.2021.06.020","volume":"81","author":"E Conway","year":"2021","unstructured":"Conway E, et al. BAP1 enhances Polycomb repression by counteracting widespread H2AK119ub1 deposition and chromatin condensation. Mol Cell. 2021;81(17):3526-3541.e8. https:\/\/doi.org\/10.1016\/j.molcel.2021.06.020.","journal-title":"Mol Cell"},{"key":"579_CR9","doi-asserted-by":"publisher","first-page":"102091","DOI":"10.1016\/j.ctrv.2020.102091","volume":"90","author":"BH Louie","year":"2020","unstructured":"Louie BH, Kurzrock R. BAP1: not just a BRCA1-associated protein. Cancer Treat Rev. 2020;90:102091. https:\/\/doi.org\/10.1016\/j.ctrv.2020.102091.","journal-title":"Cancer Treat Rev"},{"issue":"10","key":"579_CR10","doi-asserted-by":"publisher","first-page":"1181","DOI":"10.1038\/s41556-018-0178-0","volume":"20","author":"Y Zhang","year":"2018","unstructured":"Zhang Y, et al. BAP1 links metabolic regulation of ferroptosis to tumour suppression. Nat Cell Biol. 2018;20(10):1181\u201392. https:\/\/doi.org\/10.1038\/s41556-018-0178-0.","journal-title":"Nat Cell Biol"},{"issue":"9","key":"579_CR11","doi-asserted-by":"publisher","first-page":"1097","DOI":"10.1038\/sj.onc.1201861","volume":"16","author":"DE Jensen","year":"1998","unstructured":"Jensen DE, et al. BAP1: A novel ubiquitin hydrolase which binds to the BRCA1 RING finger and enhances BRCA1-mediated cell growth suppression. Oncogene. 1998;16(9):1097\u2013112. https:\/\/doi.org\/10.1038\/sj.onc.1201861.","journal-title":"Oncogene"},{"issue":"8","key":"579_CR12","doi-asserted-by":"publisher","first-page":"1103","DOI":"10.1158\/2159-8290.CD-19-1220","volume":"10","author":"M Carbone","year":"2020","unstructured":"Carbone M, et al. Biological mechanisms and clinical signifi cance of BAP1 mutations in human cancer. Cancer Discov. 2020;10(8):1103\u201320. https:\/\/doi.org\/10.1158\/2159-8290.CD-19-1220.","journal-title":"Cancer Discov"},{"issue":"1","key":"579_CR13","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1158\/0008-5472.CAN-08-3355","volume":"69","author":"H Nishikawa","year":"2009","unstructured":"Nishikawa H, et al. BRCA1-associated protein 1 interferes with BRCA1\/BARD1 RING heterodimer activity. Cancer Res. 2009;69(1):111\u20139. https:\/\/doi.org\/10.1158\/0008-5472.CAN-08-3355.","journal-title":"Cancer Res"},{"issue":"16","key":"579_CR14","doi-asserted-by":"publisher","first-page":"4282","DOI":"10.1158\/0008-5472.CAN-13-3109","volume":"74","author":"IH Ismail","year":"2014","unstructured":"Ismail IH, Davidson R, Gagn\u00e9 JP, Xu ZZ, Poirier GG, Hendzel MJ. Germline mutations in BAP1 impair its function in DNA double-strand break repair. Cancer Res. 2014;74(16):4282\u201394. https:\/\/doi.org\/10.1158\/0008-5472.CAN-13-3109.","journal-title":"Cancer Res"},{"issue":"2","key":"579_CR15","doi-asserted-by":"publisher","first-page":"606","DOI":"10.1038\/s41418-020-00709-4","volume":"28","author":"L Masclef","year":"2021","unstructured":"Masclef L, et al. Roles and mechanisms of BAP1 deubiquitinase in tumor suppression. Cell Death Differ. 2021;28(2):606\u201325. https:\/\/doi.org\/10.1038\/s41418-020-00709-4.","journal-title":"Cell Death Differ"},{"issue":"3","key":"579_CR16","doi-asserted-by":"publisher","first-page":"600","DOI":"10.1158\/1078-0432.CCR-17-1573","volume":"24","author":"X Liu","year":"2018","unstructured":"Liu X, et al. BAP1 is a novel target in HPV-negative head and neck cancer. Clin Cancer Res. 2018;24(3):600\u20137. https:\/\/doi.org\/10.1158\/1078-0432.CCR-17-1573.","journal-title":"Clin Cancer Res"},{"issue":"5","key":"579_CR17","doi-asserted-by":"publisher","first-page":"402","DOI":"10.3322\/caac.21572","volume":"69","author":"M Carbone","year":"2019","unstructured":"Carbone M, et al. Mesothelioma: scientific clues for prevention, diagnosis, and therapy. CA Cancer J Clin. 2019;69(5):402\u201329. https:\/\/doi.org\/10.3322\/caac.21572.","journal-title":"CA Cancer J Clin"},{"key":"579_CR18","doi-asserted-by":"publisher","DOI":"10.1038\/s41388-022-02240-x","author":"N Tsuboyama","year":"2022","unstructured":"Tsuboyama N, et al. Therapeutic targeting of BAP1\/ASXL3 sub-complex in ASCL1-dependent small cell lung cancer. Oncogene. 2022. https:\/\/doi.org\/10.1038\/s41388-022-02240-x.","journal-title":"Oncogene"},{"issue":"9","key":"579_CR19","doi-asserted-by":"publisher","first-page":"533","DOI":"10.1038\/s41568-020-0265-y","volume":"20","author":"M Carbone","year":"2020","unstructured":"Carbone M, et al. Tumour predisposition and cancer syndromes as models to study gene\u2013environment interaction. Nat Rev Cancer. 2020;20(9):533\u201349. https:\/\/doi.org\/10.1038\/s41568-020-0265-y.","journal-title":"Nat Rev Cancer"},{"issue":"1","key":"579_CR20","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1186\/s13062-021-00298-3","volume":"16","author":"E Panatta","year":"2021","unstructured":"Panatta E, Zampieri C, Melino G, Amelio I. Understanding p53 tumour suppressor network. Biol Direct. 2021;16(1):10\u20136. https:\/\/doi.org\/10.1186\/s13062-021-00298-3.","journal-title":"Biol Direct"},{"key":"579_CR21","doi-asserted-by":"publisher","DOI":"10.1038\/s41420-021-00406-2","author":"AP Szczepanski","year":"2021","unstructured":"Szczepanski AP, Wang L. Emerging multifaceted roles of BAP1 complexes in biological processes. Cell Death Discov. 2021. https:\/\/doi.org\/10.1038\/s41420-021-00406-2.","journal-title":"Cell Death Discov"},{"issue":"1","key":"579_CR22","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41467-020-19722-9","volume":"11","author":"H Barbour","year":"2020","unstructured":"Barbour H, Daou S, Hendzel M, Affar EB. Polycomb group-mediated histone H2A monoubiquitination in epigenome regulation and nuclear processes. Nat Commun. 2020;11(1):1\u201316. https:\/\/doi.org\/10.1038\/s41467-020-19722-9.","journal-title":"Nat Commun"},{"issue":"11","key":"579_CR23","doi-asserted-by":"publisher","first-page":"1205","DOI":"10.1038\/cr.2015.121","volume":"25","author":"X Wu","year":"2015","unstructured":"Wu X, et al. Tumor suppressor ASXL1 is essential for the activation of INK4B expression in response to oncogene activity and anti-proliferative signals. Cell Res. 2015;25(11):1205\u201318. https:\/\/doi.org\/10.1038\/cr.2015.121.","journal-title":"Cell Res"},{"issue":"3","key":"579_CR24","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1016\/j.tig.2017.11.007","volume":"34","author":"M Mallo","year":"2018","unstructured":"Mallo M. Reassessing the role of Hox genes during vertebrate development and evolution. Trends Genet. 2018;34(3):209\u201317. https:\/\/doi.org\/10.1016\/j.tig.2017.11.007.","journal-title":"Trends Genet"},{"key":"579_CR25","doi-asserted-by":"publisher","DOI":"10.1007\/s12672-021-00408-7","author":"Y Miao","year":"2021","unstructured":"Miao Y, Zhang W, Liu S, Leng X, Hu C, Sun H. HOXC10 promotes growth and migration of melanoma by regulating Slug to activate the YAP\/TAZ signaling pathway. Discov Oncol. 2021. https:\/\/doi.org\/10.1007\/s12672-021-00408-7.","journal-title":"Discov Oncol"},{"issue":"5","key":"579_CR26","doi-asserted-by":"publisher","first-page":"361","DOI":"10.1038\/nrc2826","volume":"10","author":"N Shah","year":"2010","unstructured":"Shah N, Sukumar S. The Hox genes and their roles in oncogenesis. Nat Rev Cancer. 2010;10(5):361\u201371. https:\/\/doi.org\/10.1038\/nrc2826.","journal-title":"Nat Rev Cancer"},{"key":"579_CR27","doi-asserted-by":"publisher","DOI":"10.1007\/s12672-021-00422-9","author":"Q Sun","year":"2021","unstructured":"Sun Q, Melino G, Amelio I, Jiang J, Wang Y, Shi Y. Recent advances in cancer immunotherapy. Discov Oncol. 2021. https:\/\/doi.org\/10.1007\/s12672-021-00422-9.","journal-title":"Discov Oncol"},{"issue":"17","key":"579_CR28","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1172\/jci153437","volume":"132","author":"J Yan","year":"2022","unstructured":"Yan J, et al. Tumor-intrinsic PRC2 inactivation drives a context-dependent immune-desert microenvironment and is sensitized by immunogenic viruses. J Clin Invest. 2022;132(17):1\u201316. https:\/\/doi.org\/10.1172\/jci153437.","journal-title":"J Clin Invest"},{"issue":"6","key":"579_CR29","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1371\/journal.pgen.1007362","volume":"14","author":"A Nebbioso","year":"2018","unstructured":"Nebbioso A, Tambaro FP, Dell\u2019Aversana C, Altucci L. Cancer epigenetics: moving forward. PLoS Genet. 2018;14(6):1\u201325. https:\/\/doi.org\/10.1371\/journal.pgen.1007362.","journal-title":"PLoS Genet"},{"key":"579_CR30","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12943-020-01173-x","volume":"19","author":"B Jin","year":"2020","unstructured":"Jin B, et al. Verification of EZH2 as a druggable target in metastatic uveal melanoma. Mol Cancer. 2020;19:1\u201315.","journal-title":"Mol Cancer"},{"issue":"6437","key":"579_CR31","doi-asserted-by":"publisher","first-page":"283","DOI":"10.1126\/science.aav4902","volume":"364","author":"M He","year":"2019","unstructured":"He M, et al. Intrinsic apoptosis shapes the tumor spectrum linked to inactivation of the deubiquitinase BAP1. Science. 2019;364(6437):283\u20135. https:\/\/doi.org\/10.1126\/science.aav4902.","journal-title":"Science"},{"issue":"2","key":"579_CR32","doi-asserted-by":"publisher","first-page":"538","DOI":"10.1038\/s41418-020-00697-5","volume":"28","author":"MA Basar","year":"2021","unstructured":"Basar MA, Beck DB, Werner A. Deubiquitylases in developmental ubiquitin signaling and congenital diseases. Cell Death Differ. 2021;28(2):538\u201356. https:\/\/doi.org\/10.1038\/s41418-020-00697-5.","journal-title":"Cell Death Differ"},{"key":"579_CR33","doi-asserted-by":"publisher","DOI":"10.1084\/jem.20191257","author":"J Badhai","year":"2020","unstructured":"Badhai J, et al. Combined deletion of Bap1, Nf2, and Cdkn2ab causes rapid onset of malignant mesothelioma in mice. J Exp Med. 2020. https:\/\/doi.org\/10.1084\/jem.20191257.","journal-title":"J Exp Med"},{"issue":"1","key":"579_CR34","doi-asserted-by":"publisher","first-page":"279","DOI":"10.1002\/1878-0261.12844","volume":"15","author":"R Deng","year":"2021","unstructured":"Deng R, et al. BAP1 suppresses prostate cancer progression by deubiquitinating and stabilizing PTEN. Mol Oncol. 2021;15(1):279\u201398. https:\/\/doi.org\/10.1002\/1878-0261.12844.","journal-title":"Mol Oncol"},{"issue":"5","key":"579_CR35","first-page":"1455","volume":"10","author":"J Xiao","year":"2020","unstructured":"Xiao J, Zhang R, Peng J, Yang Z. BAP1 maintains chromosome stability by stabilizing DIDO1 in renal cell carcinoma. Am J Cancer Res. 2020;10(5):1455\u201366.","journal-title":"Am J Cancer Res"},{"issue":"8","key":"579_CR36","doi-asserted-by":"publisher","first-page":"1656","DOI":"10.1158\/0008-5472.CAN-19-1704","volume":"80","author":"HJ Lee","year":"2020","unstructured":"Lee HJ, et al. The tumor suppressor BAP1 regulates the hippo pathway in pancreatic ductal adenocarcinoma. Cancer Res. 2020;80(8):1656\u201368. https:\/\/doi.org\/10.1158\/0008-5472.CAN-19-1704.","journal-title":"Cancer Res"},{"key":"579_CR37","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-020-16589-8","author":"S Perkail","year":"2020","unstructured":"Perkail S, Andricovich J, Kai Y, Tzatsos A. BAP1 is a haploinsufficient tumor suppressor linking chronic pancreatitis to pancreatic cancer in mice. Nat Commun. 2020. https:\/\/doi.org\/10.1038\/s41467-020-16589-8.","journal-title":"Nat Commun"},{"issue":"10","key":"579_CR38","doi-asserted-by":"publisher","first-page":"2931","DOI":"10.1038\/s41418-021-00793-0","volume":"28","author":"X Wang","year":"2021","unstructured":"Wang X, et al. Arginine methyltransferase PRMT5 methylates and stabilizes KLF5 via decreasing its phosphorylation and ubiquitination to promote basal-like breast cancer. Cell Death Differ. 2021;28(10):2931\u201345. https:\/\/doi.org\/10.1038\/s41418-021-00793-0.","journal-title":"Cell Death Differ"},{"key":"579_CR39","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/ncomms9471","volume":"6","author":"J Qin","year":"2015","unstructured":"Qin J, et al. BAP1 promotes breast cancer cell proliferation and metastasis by deubiquitinating KLF5. Nat Commun. 2015;6:1\u201312. https:\/\/doi.org\/10.1038\/ncomms9471.","journal-title":"Nat Commun"},{"issue":"5","key":"579_CR40","doi-asserted-by":"publisher","first-page":"515","DOI":"10.1038\/s43018-021-00199-4","volume":"2","author":"L Wang","year":"2021","unstructured":"Wang L, et al. Epigenetic targeted therapy of stabilized BAP1 in ASXL1 gain-of-function mutated leukemia. Nat Cancer. 2021;2(5):515\u201326. https:\/\/doi.org\/10.1038\/s43018-021-00199-4.","journal-title":"Nat Cancer"},{"issue":"8","key":"579_CR41","doi-asserted-by":"publisher","first-page":"1834","DOI":"10.1038\/s41375-018-0126-9","volume":"32","author":"Y Guo","year":"2018","unstructured":"Guo Y, et al. Reduced BAP1 activity prevents ASXL1 truncation-driven myeloid malignancy in vivo. Leukemia. 2018;32(8):1834\u20137. https:\/\/doi.org\/10.1038\/s41375-018-0126-9.","journal-title":"Leukemia"},{"issue":"11","key":"579_CR42","doi-asserted-by":"publisher","first-page":"1344","DOI":"10.1038\/nm.3947.Loss","volume":"21","author":"LM Lafave","year":"2016","unstructured":"Lafave LM, et al. Loss of BAP1 function leads to EZH2-dependent transformation. Nat Med. 2016;21(11):1344\u20139. https:\/\/doi.org\/10.1038\/nm.3947.Loss.","journal-title":"Nat Med"},{"key":"579_CR43","doi-asserted-by":"publisher","DOI":"10.1126\/science.1221711.Loss","author":"A Dey","year":"2012","unstructured":"Dey A, et al. Loss of the tumor suppressor BAP1 causes myeloid transformation. Science. 2012. https:\/\/doi.org\/10.1126\/science.1221711.Loss.","journal-title":"Science"},{"issue":"3","key":"579_CR44","doi-asserted-by":"publisher","first-page":"392","DOI":"10.1016\/j.molcel.2014.03.002","volume":"54","author":"N Mashtalir","year":"2014","unstructured":"Mashtalir N, et al. Autodeubiquitination protects the tumor suppressor BAP1 from cytoplasmic sequestration mediated by the atypical ubiquitin ligase UBE2O. Mol Cell. 2014;54(3):392\u2013406. https:\/\/doi.org\/10.1016\/j.molcel.2014.03.002.","journal-title":"Mol Cell"},{"issue":"7659","key":"579_CR45","doi-asserted-by":"publisher","first-page":"549","DOI":"10.1038\/nature22798","volume":"546","author":"A Bononi","year":"2017","unstructured":"Bononi A, et al. BAP1 regulates IP3R3-mediated Ca 2+ flux to mitochondria suppressing cell transformation. Nature. 2017;546(7659):549\u201353. https:\/\/doi.org\/10.1038\/nature22798.","journal-title":"Nature"},{"key":"579_CR46","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-018-06186-1","author":"M Foglizzo","year":"2018","unstructured":"Foglizzo M, et al. A bidentate Polycomb Repressive-Deubiquitinase complex is required for efficient activity on nucleosomes. Nat Commun. 2018. https:\/\/doi.org\/10.1038\/s41467-018-06186-1.","journal-title":"Nat Commun"},{"key":"579_CR47","doi-asserted-by":"publisher","DOI":"10.21037\/pcm-21-12","author":"AA Zolondick","year":"2022","unstructured":"Zolondick AA, Gaudino G, Xue J, Pass HI, Carbone M, Yang H. Asbestos-induced chronic inflammation in malignant pleural mesothelioma and related therapeutic approaches\u2014a narrative review. Precis Cancer Med. 2022. https:\/\/doi.org\/10.21037\/pcm-21-12.","journal-title":"Precis Cancer Med"},{"issue":"1","key":"579_CR48","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1038\/s41418-021-00841-9","volume":"29","author":"K Yang","year":"2022","unstructured":"Yang K, et al. Lactate promotes macrophage HMGB1 lactylation, acetylation, and exosomal release in polymicrobial sepsis. Cell Death Differ. 2022;29(1):133\u201346. https:\/\/doi.org\/10.1038\/s41418-021-00841-9.","journal-title":"Cell Death Differ"},{"issue":"1","key":"579_CR49","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s13062-021-00313-7","volume":"16","author":"EV Sazonova","year":"2021","unstructured":"Sazonova EV, Petrichuk SV, Kopeina GS, Zhivotovsky B. A link between mitotic defects and mitotic catastrophe: detection and cell fate. Biol Direct. 2021;16(1):1\u201311. https:\/\/doi.org\/10.1186\/s13062-021-00313-7.","journal-title":"Biol Direct"},{"issue":"10","key":"579_CR50","doi-asserted-by":"publisher","first-page":"2498","DOI":"10.1158\/1535-7163.MCT-16-0229","volume":"15","author":"S Kato","year":"2016","unstructured":"Kato S, Tomson BN, Buys TPH, Elkin SK, Carter JL, Kurzrock R. Genomic landscape of malignant mesotheliomas. Mol Cancer Ther. 2016;15(10):2498\u2013507. https:\/\/doi.org\/10.1158\/1535-7163.MCT-16-0229.","journal-title":"Mol Cancer Ther"},{"issue":"5","key":"579_CR51","doi-asserted-by":"publisher","first-page":"537","DOI":"10.1038\/onc.2015.125","volume":"35","author":"AM Petrilli","year":"2016","unstructured":"Petrilli AM, Fern\u00e1ndez-Valle C. Role of Merlin\/NF2 inactivation in tumor biology. Oncogene. 2016;35(5):537\u201348. https:\/\/doi.org\/10.1038\/onc.2015.125.","journal-title":"Oncogene"},{"issue":"3","key":"579_CR52","doi-asserted-by":"publisher","first-page":"607","DOI":"10.1002\/1878-0261.13128","volume":"16","author":"L Yu","year":"2022","unstructured":"Yu L, et al. Co-occurrence of BAP1 and SF3B1 mutations in uveal melanoma induces cellular senescence. Mol Oncol. 2022;16(3):607\u201329. https:\/\/doi.org\/10.1002\/1878-0261.13128.","journal-title":"Mol Oncol"},{"issue":"1","key":"579_CR53","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1007\/s10555-017-9663-3","volume":"36","author":"A Amaro","year":"2017","unstructured":"Amaro A, et al. The biology of uveal melanoma. Cancer Metastasis Rev. 2017;36(1):109\u201340. https:\/\/doi.org\/10.1007\/s10555-017-9663-3.","journal-title":"Cancer Metastasis Rev"},{"issue":"2","key":"579_CR54","doi-asserted-by":"publisher","first-page":"241","DOI":"10.1038\/eye.2016.275","volume":"31","author":"S Kaliki","year":"2016","unstructured":"Kaliki S, Shields CL. Uveal melanoma\u202f: relatively rare but deadly cancer. Eye. 2016;31(2):241\u201357. https:\/\/doi.org\/10.1038\/eye.2016.275.","journal-title":"Eye"},{"issue":"1","key":"579_CR55","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1038\/s41572-020-0158-0","volume":"6","author":"MJ Jager","year":"2020","unstructured":"Jager MJ, et al. Uveal melanoma. Nat Rev Dis Prim. 2020;6(1):18\u201320. https:\/\/doi.org\/10.1038\/s41572-020-0158-0.","journal-title":"Nat Rev Dis Prim"},{"issue":"6","key":"579_CR56","doi-asserted-by":"publisher","first-page":"1990","DOI":"10.1038\/s41418-020-00730-7","volume":"28","author":"C Pandiani","year":"2021","unstructured":"Pandiani C, et al. Single-cell RNA sequencing reveals intratumoral heterogeneity in primary uveal melanomas and identifies HES6 as a driver of the metastatic disease. Cell Death Differ. 2021;28(6):1990\u20132000. https:\/\/doi.org\/10.1038\/s41418-020-00730-7.","journal-title":"Cell Death Differ"},{"issue":"8","key":"579_CR57","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3390\/cancers11081102","volume":"11","author":"Z Souri","year":"2019","unstructured":"Souri Z, et al. Loss of BAP1 is associated with upregulation of the NFkB pathway and increased HLA class I expression in Uveal Melanoma. Cancers (Basel). 2019;11(8):1\u201316. https:\/\/doi.org\/10.3390\/cancers11081102.","journal-title":"Cancers (Basel)"},{"issue":"1","key":"579_CR58","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41467-021-25529-z","volume":"12","author":"MF Bakhoum","year":"2021","unstructured":"Bakhoum MF, et al. Loss of polycomb repressive complex 1 activity and chromosomal instability drive uveal melanoma progression. Nat Commun. 2021;12(1):1\u201316. https:\/\/doi.org\/10.1038\/s41467-021-25529-z.","journal-title":"Nat Commun"},{"key":"579_CR59","doi-asserted-by":"publisher","DOI":"10.1016\/j.preteyeres.2019.100800","author":"KN Smit","year":"2019","unstructured":"Smit KN, Jager MJ, de Klein A, Kili\u04ab E. Uveal melanoma: towards a molecular understanding. Prog Retin Eye Res. 2019. https:\/\/doi.org\/10.1016\/j.preteyeres.2019.100800.","journal-title":"Prog Retin Eye Res"},{"key":"579_CR60","doi-asserted-by":"publisher","DOI":"10.1007\/s12672-021-00414-9","author":"Y Liu","year":"2021","unstructured":"Liu Y, Zhuang Y, Fu X, Li C. LncRNA POU3F3 promotes melanoma cell proliferation by downregulating lncRNA MEG3. Discov Oncol. 2021. https:\/\/doi.org\/10.1007\/s12672-021-00414-9.","journal-title":"Discov Oncol"},{"issue":"8","key":"579_CR61","doi-asserted-by":"publisher","first-page":"724","DOI":"10.1101\/gad.296962.117","volume":"31","author":"C Pandiani","year":"2017","unstructured":"Pandiani C, B\u00e9ranger GE, Leclerc J, Ballotti R, Bertolotto C. Focus on cutaneous and uveal melanoma specificities. Genes Dev. 2017;31(8):724\u201343. https:\/\/doi.org\/10.1101\/gad.296962.117.","journal-title":"Genes Dev"},{"issue":"1","key":"579_CR62","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41467-020-16276-8","volume":"11","author":"PA Johansson","year":"2020","unstructured":"Johansson PA, et al. Whole genome landscapes of uveal melanoma show an ultraviolet radiation signature in iris tumours. Nat Commun. 2020;11(1):1\u20138. https:\/\/doi.org\/10.1038\/s41467-020-16276-8.","journal-title":"Nat Commun"},{"issue":"7","key":"579_CR63","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3390\/cancers13071700","volume":"13","author":"M Chalada","year":"2021","unstructured":"Chalada M, Ramlogan-Steel CA, Dhungel BP, Layton CJ, Steel JC. The impact of ultraviolet radiation on the aetiology and development of uveal melanoma. Cancers (Basel). 2021;13(7):1\u201317. https:\/\/doi.org\/10.3390\/cancers13071700.","journal-title":"Cancers (Basel)"},{"key":"579_CR64","doi-asserted-by":"publisher","first-page":"118632","DOI":"10.1016\/j.lfs.2020.118632","volume":"264","author":"D Singh","year":"2021","unstructured":"Singh D. Current updates and future perspectives on the management of renal cell carcinoma. Life Sci. 2021;264:118632. https:\/\/doi.org\/10.1016\/j.lfs.2020.118632.","journal-title":"Life Sci"},{"issue":"4","key":"579_CR65","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1038\/s41581-020-00359-2","volume":"17","author":"E Jonasch","year":"2021","unstructured":"Jonasch E, Walker CL, Rathmell WK. Clear cell renal cell carcinoma ontogeny and mechanisms of lethality. Nat Rev Nephrol. 2021;17(4):245\u201361. https:\/\/doi.org\/10.1038\/s41581-020-00359-2.","journal-title":"Nat Rev Nephrol"},{"issue":"6","key":"579_CR66","doi-asserted-by":"publisher","first-page":"378","DOI":"10.4132\/jptm.2018.09.21","volume":"52","author":"YC Wi","year":"2018","unstructured":"Wi YC, et al. Loss of nuclear BAP1 expression is associated with high WHO\/ISUP grade in clear cell renal cell carcinoma. J Pathol Transl Med. 2018;52(6):378\u201385. https:\/\/doi.org\/10.4132\/jptm.2018.09.21.","journal-title":"J Pathol Transl Med"},{"issue":"1","key":"579_CR67","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1016\/j.canlet.2015.08.013","volume":"369","author":"J Peng","year":"2015","unstructured":"Peng J, et al. Stabilization of MCRS1 by BAP1 prevents chromosome instability in renal cell carcinoma. Cancer Lett. 2015;369(1):167\u201374. https:\/\/doi.org\/10.1016\/j.canlet.2015.08.013.","journal-title":"Cancer Lett"},{"issue":"8","key":"579_CR68","doi-asserted-by":"publisher","first-page":"900","DOI":"10.1158\/2159-8290.CD-17-0292","volume":"7","author":"YF Gu","year":"2017","unstructured":"Gu YF, et al. Modeling renal cell carcinoma in mice: Bap1 and Pbrm1 inactivation drive tumor grade. Cancer Discov. 2017;7(8):900\u201317. https:\/\/doi.org\/10.1158\/2159-8290.CD-17-0292.","journal-title":"Cancer Discov"},{"key":"579_CR69","doi-asserted-by":"publisher","DOI":"10.1136\/jitc-2019-000228","author":"Q Zhou","year":"2020","unstructured":"Zhou Q, et al. CCR5 blockade inflames antitumor immunity in BAP1-mutant clear cell renal cell carcinoma. J Immunother Cancer. 2020. https:\/\/doi.org\/10.1136\/jitc-2019-000228.","journal-title":"J Immunother Cancer"},{"issue":"3","key":"579_CR70","doi-asserted-by":"publisher","first-page":"932","DOI":"10.1038\/s41418-020-00626-6","volume":"28","author":"C Wang","year":"2021","unstructured":"Wang C, et al. Targeting a positive regulatory loop in the tumor-macrophage interaction impairs the progression of clear cell renal cell carcinoma. Cell Death Differ. 2021;28(3):932\u201351. https:\/\/doi.org\/10.1038\/s41418-020-00626-6.","journal-title":"Cell Death Differ"},{"issue":"1","key":"579_CR71","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s13062-020-00274-3","volume":"15","author":"I Amelio","year":"2020","unstructured":"Amelio I, et al. Cancer predictive studies. Biol Direct. 2020;15(1):1\u20137. https:\/\/doi.org\/10.1186\/s13062-020-00274-3.","journal-title":"Biol Direct"},{"key":"579_CR72","doi-asserted-by":"publisher","DOI":"10.1038\/s41419-018-1087-7","author":"XX Chen","year":"2018","unstructured":"Chen XX, et al. BAP1 acts as a tumor suppressor in intrahepatic cholangiocarcinoma by modulating the ERK1\/2 and JNK\/c-Jun pathways. Cell Death Dis. 2018. https:\/\/doi.org\/10.1038\/s41419-018-1087-7.","journal-title":"Cell Death Dis"},{"key":"579_CR73","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.CCR-19-0366.BAP1","author":"MG Field","year":"2019","unstructured":"Field MG, et al. BAP1 loss is associated with DNA methylomic repatterning in highly aggressive Class 2 uveal melanomas. Clin Cancer Res. 2019. https:\/\/doi.org\/10.1158\/1078-0432.CCR-19-0366.BAP1.","journal-title":"Clin Cancer Res"},{"issue":"48","key":"579_CR74","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1073\/pnas.2111946118","volume":"118","author":"F Novelli","year":"2021","unstructured":"Novelli F, et al. BAP1 forms a trimer with HMGB1 and HDAC1 that modulates gene \u00d7 environment interaction with asbestos. Proc Natl Acad Sci USA. 2021;118(48):1\u201311. https:\/\/doi.org\/10.1073\/pnas.2111946118.","journal-title":"Proc Natl Acad Sci USA"},{"key":"579_CR75","doi-asserted-by":"publisher","DOI":"10.1158\/2159-8290.CD-12-0095","author":"E Cerami","year":"2012","unstructured":"Cerami E, et al. The cBio Cancer Genomics Portal: an open platform for exploring multidimensional cancer genomics data. Cancer Discov. 2012. https:\/\/doi.org\/10.1158\/2159-8290.CD-12-0095.","journal-title":"Cancer Discov"}],"container-title":["Discover Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12672-022-00579-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12672-022-00579-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12672-022-00579-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,11,1]],"date-time":"2022-11-01T23:09:59Z","timestamp":1667344199000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12672-022-00579-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,11,1]]},"references-count":75,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2022,12]]}},"alternative-id":["579"],"URL":"https:\/\/doi.org\/10.1007\/s12672-022-00579-x","relation":{},"ISSN":["2730-6011"],"issn-type":[{"value":"2730-6011","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,11,1]]},"assertion":[{"value":"20 September 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 October 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 November 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare that they have no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"117"}}